KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-17 Cr |
Mar2023 | ₹0.99 Cr |
Mar2022 | ₹5.66 Cr |
Mar2021 | ₹0.77 Cr |
Mar2020 | ₹12 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-17 Cr | Negative | |
Mar2023 | ₹0.99 Cr | -82.43 | |
Mar2022 | ₹5.66 Cr | 637.55 | |
Mar2021 | ₹0.77 Cr | -93.48 | |
Mar2020 | ₹12 Cr | - |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹840.8 Cr | 1.7% | -16.7% | 72% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 1.7% |
-16.7% |
72% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses